CollPlant Biotechnologies (CLGN) Enterprise Value (2017 - 2025)
Historic Enterprise Value for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to -$11.9 million.
- CollPlant Biotechnologies' Enterprise Value rose 9555.09% to -$11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year increase of 9555.09%. This contributed to the annual value of -$26.9 million for FY2024, which is 2.6% down from last year.
- As of Q3 2025, CollPlant Biotechnologies' Enterprise Value stood at -$11.9 million, which was up 9555.09% from -$12.2 million recorded in Q2 2025.
- CollPlant Biotechnologies' 5-year Enterprise Value high stood at -$11.9 million for Q3 2025, and its period low was -$213.0 billion during Q4 2021.
- Over the past 5 years, CollPlant Biotechnologies' median Enterprise Value value was -$33.0 million (recorded in 2022), while the average stood at -$11.3 billion.
- Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 574614084.17% in 2021, then skyrocketed by 9990.55% in 2022.
- Over the past 5 years, CollPlant Biotechnologies' Enterprise Value (Quarter) stood at -$213.0 billion in 2021, then surged by 99.91% to -$201.4 million in 2022, then skyrocketed by 86.63% to -$26.9 million in 2023, then surged by 54.83% to -$12.2 million in 2024, then grew by 2.04% to -$11.9 million in 2025.
- Its Enterprise Value stands at -$11.9 million for Q3 2025, versus -$12.2 million for Q2 2025 and -$256.9 million for Q1 2025.